{"result": "{\n    \"title\": \"Global Impact of the ADRENAL Trial on Septic Shock Treatment\",\n    \"summary\": \"This report examines the ADRENAL trial and its global impact on the treatment of septic shock, focusing on the roles of corticosteroids, ICU management, and the international collaboration across countries. It highlights the critical findings from the trial, the use of corticosteroids in septic shock treatment, and the significant contributions from various countries and institutions.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The high impact severity rating reflects the significant global contribution to medical research and potential changes in clinical practices for treating septic shock.\",\n    \"findings\": [\n        {\n            \"summary\": \"The pivotal role of the ADRENAL trial in septic shock treatment\",\n            \"explanation\": \"The ADRENAL trial, a key study assessing the efficacy of hydrocortisone in reducing mortality among septic shock patients, represents a cornerstone in critical care medicine. This trial, sponsored by the George Institute for Global Health, Australia, and funded by the National Health and Medical Research Council of Australia, involved multiple countries, including Australia, the United Kingdom, New Zealand, Saudi Arabia, and Denmark, showcasing an impressive international effort in medical research [Data: Entities (50, 52, 48); Relationships (36, 109, 110, 111, 112, 113)]. The trial's findings have the potential to influence treatment protocols worldwide, underscoring the importance of global collaboration in advancing healthcare.\"\n        },\n        {\n            \"summary\": \"Corticosteroids' role in septic shock management\",\n            \"explanation\": \"Corticosteroids, particularly hydrocortisone, have been extensively studied for their potential to reduce mortality in septic shock patients. Despite mixed outcomes, the consistent investigation into corticosteroids' effectiveness highlights their critical role in septic shock management. The ADRENAL trial and other studies, such as the CORTICUS study, contribute to a nuanced understanding of when and how corticosteroids can be most beneficial for patients [Data: Entities (2, 50); Relationships (6, 1, 10)]. This ongoing research is vital for refining treatment strategies and improving patient outcomes in critical care settings.\"\n        },\n        {\n            \"summary\": \"The ICU's critical role in septic shock treatment and research\",\n            \"explanation\": \"Intensive Care Units (ICUs) are at the forefront of treating septic shock, a condition requiring close monitoring and advanced medical interventions. The ADRENAL trial and related studies underscore the ICU's pivotal role in both patient care and clinical research. Outcomes such as mortality rates, duration of stay, and the time required to wean patients from mechanical ventilation are crucial metrics used to assess treatment efficacy in these settings [Data: Entities (16); Relationships (5, 55, 62)]. The ICU's involvement in these trials is instrumental in advancing our understanding of septic shock treatment.\"\n        },\n        {\n            \"summary\": \"Global collaboration enhances septic shock research\",\n            \"explanation\": \"The ADRENAL trial's international scope, with participation from countries like Australia, the United Kingdom, New Zealand, Saudi Arabia, and Denmark, exemplifies the importance of global collaboration in medical research. This collective effort not only diversifies the patient population in clinical trials but also enriches the research with a variety of healthcare practices and perspectives. Such collaboration is crucial for developing universally applicable treatment guidelines and advancing the field of critical care medicine [Data: Entities (53, 54, 55, 56, 57); Relationships (109, 110, 111, 112, 113)].\"\n        },\n        {\n            \"summary\": \"The impact of corticosteroids on ICU discharge and mortality rates\",\n            \"explanation\": \"One of the significant findings from the ADRENAL trial and related research is the impact of corticosteroids on ICU discharge times and mortality rates. While the results have been mixed, the data suggest that corticosteroids, including hydrocortisone, can influence the duration of ICU stays and potentially affect patient survival outcomes. These findings are critical for ICU protocols and patient management strategies, highlighting the need for ongoing research to optimize treatment approaches for septic shock [Data: Relationships (6, 62, 78)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n16,ICU,\"The Intensive Care Unit (ICU) is a specialized department in hospitals dedicated to providing intensive care medicine to patients with severe or life-threatening illnesses or injuries. It is a critical care unit where patient mortality rates and durations of stay are meticulously measured, highlighting its role in treating the most critical cases. The ICU is essential for patients requiring constant monitoring and life support, underscoring its importance in the healthcare system. Additionally, discharge outcomes from the ICU are a significant aspect of its operation, indicating the critical nature of the care provided and the unit's role in patient recovery trajectories.\",10\n50,ADRENAL TRIAL,A clinical trial named Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock that tested the hypothesis that hydrocortisone reduces mortality in septic shock patients,10\n2,CORTICOSTEROIDS,\"Corticosteroids are a class of medications that play a significant role in the medical field, particularly in the treatment of septic shock. These drugs are utilized in studies to evaluate their effectiveness in managing septic shock patients. Additionally, corticosteroids serve as a treatment option for this condition by aiming to replace low hormone levels caused by adrenal insufficiency. This dual purpose underscores their importance in critical care and their potential impact on patient outcomes in life-threatening situations.\",6\n9,PLACEBO,\"Placebo is a control substance with no therapeutic effect, used in clinical trials to compare the effectiveness of various treatments. Specifically, it has been utilized in studies to assess the effects of corticosteroids, such as hydrocortisone plus fludrocortisone, on patients with septic shock. In these trials, the placebo serves as a benchmark to determine the actual efficacy of the corticosteroids being tested. One such clinical trial involved comparing the effects of hydrocortisone against a placebo in patients with septic shock who were undergoing mechanical ventilation. For this purpose, the placebo was supplied by Radpharm Scientific. This approach ensures that the results of the clinical trials are reliable by providing a clear contrast between the effects of the treatment and the absence of treatment, thereby highlighting the true impact of the corticosteroids on septic shock.\",5\n15,VASOPRESSORS,\"Vasopressors are medications that are utilized to increase blood pressure in critically ill patients. Their relationship to adverse events was assessed in the study, highlighting their importance in the management of acute medical conditions where maintaining adequate blood pressure is crucial for patient survival. These drugs play a key role in the treatment protocols of intensive care units, ensuring that patients with life-threatening hypotension receive the necessary intervention to stabilize their condition.\",2\n101,SOFA SCORE,\"The SOFA Score, or Sequential Organ Failure Assessment score, is a scoring system used to track a patient's status during their stay in the Intensive Care Unit (ICU). It focuses on assessing organ failure, with lower scores indicating better organ function. The system is instrumental in monitoring the patient's progress over time, and it has been utilized in clinical trials to compare the effectiveness of treatments, specifically looking at the time it takes for patients to reach a SOFA score below 6 between different treatment groups. This score is a critical tool for healthcare professionals in making informed decisions about patient care in the ICU.\",2\n85,ANNANE ET AL.,Researchers who conducted a study on septic shock treatment with hydrocortisone and fludrocortisone,1\n102,SUPERINFECTION,\"An infection occurring on top of another infection, often seen in patients with weakened immune systems\",1\n21,HOSPITAL,\"The hospital is a healthcare institution that was involved in a study measuring mortality rates, adverse events, and durations of stay. It is the medical facility where patients stayed during their treatment. The study recorded mortality rates at this hospital, focusing on the outcomes and the quality of care provided to the patients during their stay.\",3\n53,AUSTRALIA,\"Australia is a country that played a significant role in the ADRENAL trial, a clinical study focused on medical practices in intensive care units. It hosted 45 medical-surgical ICU sites that participated in the trial, highlighting its significant contribution to the research. The ADRENAL trial was an international effort, with Australia being one of the key countries where the study was conducted, alongside the United Kingdom, New Zealand, Saudi Arabia, and Denmark. This collaboration underscores Australia's position in the global medical research community, particularly in the realm of intensive care and medical-surgical studies.\",2\n54,UNITED KINGDOM,\"The United Kingdom is a country that played a significant role in medical research, specifically in the field of intensive care. It hosted 12 medical-surgical Intensive Care Unit (ICU) sites that participated in the ADRENAL trial, highlighting its contribution to this significant clinical trial. The ADRENAL trial, which was conducted in multiple countries, included the United Kingdom as a key location where the clinical research was carried out. This underscores the United Kingdom's involvement and importance in advancing medical knowledge and practices through participation in international clinical trials.\",2\n55,NEW ZEALAND,\"New Zealand is a country that played a significant role in the medical research community by participating in the ADRENAL trial. It contributed with 8 medical-surgical Intensive Care Unit (ICU) sites for this clinical trial, highlighting its commitment to advancing medical knowledge and treatments. This involvement underscores New Zealand's active participation in international clinical research efforts.\",2\n56,SAUDI ARABIA,Saudi Arabia is a country that played a significant role in the ADRENAL trial by hosting three medical-surgical ICU sites that participated in the study. This involvement underscores its contribution to the international clinical trial aimed at exploring critical health interventions.,2\n57,DENMARK,\"Denmark is a country that participated in the ADRENAL trial, hosting one medical-surgical ICU site for the clinical study. This involvement underscores Denmark's contribution to the international research effort aimed at advancing medical knowledge and practices.\",2\n52,\"GEORGE INSTITUTE FOR GLOBAL HEALTH, AUSTRALIA\",\"The sponsor of the ADRENAL trial, responsible for coordinating operational processes and conducting statistical analyses\",1\n47,INTENSIVE CARE UNIT (ICU),A specialized department in a hospital where patients with severe and life-threatening illnesses or injuries are given intensive medical care and monitoring,1\n48,NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL OF AUSTRALIA,\"An Australian organization that funded the ADRENAL trial, which investigates the efficacy of hydrocortisone in septic shock patients\",1\n18,O'BRIEN AND FLEMING,A statistical method used for interim analysis in the study to determine the significance of the results at different points,2\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n6,SEPTIC SHOCK,HYDROCORTISONE,\"Hydrocortisone has been extensively studied and used in the treatment of septic shock, particularly for its potential to reduce mortality and impact on hemodynamics in patients. It is especially considered for patients who do not respond to corticotropin, indicating its role in more resistant cases of septic shock. Various studies, including the notable ADRENAL trial, have focused on hydrocortisone's effectiveness in decreasing mortality among septic shock patients. While some research findings suggest that hydrocortisone significantly reduces mortality in these patients, there are also studies indicating that it may not decrease mortality. Despite these conflicting results, hydrocortisone remains a critical component of the therapeutic approach to managing septic shock, highlighting its importance in the medical field's ongoing efforts to improve outcomes for affected patients.\",37\n9,SEPTIC SHOCK,PLACEBO GROUP,\"The placebo group was part of a clinical trial designed to assess treatments for septic shock. This group consisted of patients who were treated for septic shock but did not receive the active medication being tested in the trial. Instead, they received a placebo as part of the study's methodology to evaluate the efficacy of the treatment under investigation.\",35\n8,SEPTIC SHOCK,HYDROCORTISONE GROUP,The Hydrocortisone Group was involved in a clinical trial focused on treating septic shock. This group comprised patients who were being treated for septic shock with hydrocortisone. The aim of the trial was to evaluate the effectiveness of hydrocortisone in managing septic shock conditions among these patients.,30\n5,SEPTIC SHOCK,ICU,\"Patients with septic shock are frequently treated in the Intensive Care Unit (ICU) due to the severity of their condition. The ICU is critical for managing such patients, where they are treated and observed closely. Outcomes such as mortality and the time required to wean patients from mechanical ventilation and vasopressor therapy are important measures of their progress and recovery in the ICU. This highlights the crucial role the ICU plays in the care and management of patients suffering from septic shock.\",29\n36,HYDROCORTISONE,ADRENAL TRIAL,Hydrocortisone was the medication tested in the ADRENAL trial to assess its efficacy in reducing mortality among septic shock patients,28\n55,ICU,PLACEBO GROUP,\"In a clinical trial, the placebo group, which was compared to the hydrocortisone group, had their time in the Intensive Care Unit (ICU) closely monitored. Additionally, the mortality rates of the placebo group were also observed while they were in the ICU. This comprehensive approach allowed researchers to assess not only the duration of ICU stay but also the survival outcomes of the placebo group in comparison to those receiving hydrocortisone treatment.\",26\n1,SEPTIC SHOCK,CORTICOSTEROIDS,\"Corticosteroids have been the subject of research to determine their effectiveness in treating septic shock, with studies yielding mixed outcomes. These studies consistently tested corticosteroids as a potential treatment option for patients suffering from septic shock, exploring their impact and assessing their therapeutic value. Despite the variations in reported results, the consistent theme across these studies is the exploration of corticosteroids' role in managing septic shock, indicating a focused interest in understanding how these drugs can influence the treatment of this critical condition.\",25\n0,SEPTIC SHOCK,ADRENAL INSUFFICIENCY,\"The study focused on the prognostic importance of adrenal insufficiency in patients with septic shock, highlighting its influence on treatment approaches. It was noted that septic shock may be associated with adrenal insufficiency, which has prompted further investigation into the efficacy of corticosteroid treatment for these conditions. This connection between septic shock and adrenal insufficiency underscores the critical need for targeted therapeutic strategies to improve patient outcomes.\",25\n18,SEPTIC SHOCK,HYDROCORTISONE PLUS FLUDROCORTISONE,The treatment regimen was used in clinical trials to assess its effectiveness in reducing mortality and the need for vasopressors in patients with septic shock,25\n3,SEPTIC SHOCK,PLACEBO,\"In the ADRENAL trial, the effectiveness of hydrocortisone in treating septic shock was evaluated by comparing it to a placebo. The placebo served as a control to assess the impact of corticosteroids, including hydrocortisone, on patients with septic shock. This comparison aimed to determine the relative effectiveness of corticosteroids against the baseline effects observed with the placebo in managing septic shock conditions.\",24\n7,SEPTIC SHOCK,FLUDROCORTISONE,\"Fludrocortisone, in combination with hydrocortisone, has been utilized in the treatment of septic shock. This approach was explored in a trial aiming to reduce mortality among septic shock patients. The use of fludrocortisone, especially when combined with hydrocortisone, represents a therapeutic strategy to improve outcomes in individuals suffering from septic shock.\",24\n14,SEPTIC SHOCK,DROTRECOGIN ALFA (ACTIVATED),\"Drotrecogin alfa (activated) was initially used in the treatment of septic shock before it was withdrawn from the market. This medication was specifically aimed at managing septic shock, a severe condition, but due to various reasons, it is no longer available for this purpose.\",24\n10,SEPTIC SHOCK,CORTICUS STUDY,\"The CORTICUS study focused on patients with septic shock, assessing the impact of hydrocortisone treatment\",23\n15,SEPTIC SHOCK,MECHANICAL VENTILATION,Mechanical ventilation is often required for patients with septic shock who develop respiratory failure,23\n62,ICU,HYDROCORTISONE GROUP,Hydrocortisone group had a shorter time to ICU discharge compared to placebo group,21\n2,SEPTIC SHOCK,GROUPE D'ETUDE ET DE RECHERCHE SUR LE MÉDICAMENT (GERMED),GERMED supported the study on corticosteroid treatment for septic shock,21\n4,SEPTIC SHOCK,VASOPRESSORS,Vasopressors are medications utilized to manage and treat the low blood pressure that is associated with septic shock. They play a crucial role in the medical management of septic shock patients by stabilizing their blood pressure.,21\n11,SEPTIC SHOCK,INTENSIVE CARE UNITS,\"Intensive Care Units treat patients with conditions like septic shock, which was the focus of the CORTICUS study\",21\n13,SEPTIC SHOCK,HYDROCORTISONE-PLUS-FLUDROCORTISONE,\"The therapy was evaluated for its effectiveness in treating septic shock, showing a reduction in mortality\",21\n16,SEPTIC SHOCK,SOFA SCORE,The SOFA score is used to assess the extent of a patient's organ function or rate of failure in the context of septic shock,21\n12,SEPTIC SHOCK,ANNANE ET AL.,Annane et al. conducted research on the treatment of septic shock,20\n17,SEPTIC SHOCK,SUPERINFECTION,Patients with septic shock are at increased risk of developing superinfections,20\n66,PLACEBO GROUP,HOSPITAL,The placebo group's mortality rates and health outcomes were recorded during their hospital stay,19\n56,ICU,CORTICOSTEROID GROUP,The corticosteroid group's mortality rates were monitored in the ICU,17\n50,PLACEBO,ADRENAL TRIAL,A placebo was used as a control in the ADRENAL trial to compare the effects of hydrocortisone in septic shock patients,15\n63,ICU,HOSPITAL,ICU is a critical department within the hospital involved in the study,13\n109,ADRENAL TRIAL,AUSTRALIA,Australia was one of the countries where the ADRENAL trial was conducted,12\n110,ADRENAL TRIAL,UNITED KINGDOM,The United Kingdom was one of the countries where the ADRENAL trial was conducted,12\n111,ADRENAL TRIAL,NEW ZEALAND,New Zealand was one of the countries where the ADRENAL trial was conducted,12\n112,ADRENAL TRIAL,SAUDI ARABIA,Saudi Arabia was one of the countries where the ADRENAL trial was conducted,12\n113,ADRENAL TRIAL,DENMARK,Denmark was one of the countries where the ADRENAL trial was conducted,12\n57,ICU,AUSTRALIA,Australia hosted 45 medical-surgical ICU sites participating in the trial,12\n21,ADRENAL INSUFFICIENCY,CORTICOSTEROIDS,\"Corticosteroids are used to treat adrenal insufficiency, particularly in critically ill patients\",12\n61,ICU,DENMARK,Denmark hosted 1 medical-surgical ICU site participating in the trial,12\n58,ICU,UNITED KINGDOM,The United Kingdom hosted 12 medical-surgical ICU sites participating in the trial,12\n59,ICU,NEW ZEALAND,New Zealand hosted 8 medical-surgical ICU sites participating in the trial,12\n60,ICU,SAUDI ARABIA,Saudi Arabia hosted 3 medical-surgical ICU sites participating in the trial,12\n108,ADRENAL TRIAL,\"GEORGE INSTITUTE FOR GLOBAL HEALTH, AUSTRALIA\",\"The George Institute for Global Health, Australia, sponsored and coordinated the ADRENAL trial\",11\n105,INTENSIVE CARE UNIT (ICU),ADRENAL TRIAL,The ADRENAL trial involved patients undergoing mechanical ventilation in the ICU,11\n106,NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL OF AUSTRALIA,ADRENAL TRIAL,The National Health and Medical Research Council of Australia funded the ADRENAL trial,11\n24,CORTICOSTEROIDS,SAS INSTITUTE,SAS statistical software by SAS Institute was used to analyze the effectiveness of corticosteroids,11\n27,CORTICOSTEROIDS,ADVERSE EVENTS,Use of corticosteroids was associated with adverse events like hyperglycemia and hypernatremia,11\n78,CORTICOSTEROID GROUP,HOSPITAL,The corticosteroid group's mortality rates and health outcomes were recorded during their hospital stay,10\n25,CORTICOSTEROIDS,O'BRIEN AND FLEMING,The O'Brien and Fleming method was used to analyze the effectiveness of corticosteroids in the study,8\n26,CORTICOSTEROIDS,GLUCOCORTICOID,Glucocorticoid is a specific type of corticosteroid used in certain treatments,8\n49,PLACEBO,O'BRIEN AND FLEMING,The O'Brien and Fleming method was used to analyze the effectiveness of placebo in the study,7\n51,PLACEBO,RADPHARM SCIENTIFIC,Radpharm Scientific supplied placebo for the clinical trial,7\n52,PLACEBO,INTENSIVE CARE UNIT,Patients in the Intensive Care Unit were treated with placebo as part of the clinical trial,7\n54,VASOPRESSORS,SAS INSTITUTE,SAS statistical software by SAS Institute was used to analyze the relationship between vasopressors and adverse events,7\n150,SOFA SCORE,HYDROCORTISONE-PLUS-FLUDROCORTISONE GROUP,Patients in the hydrocortisone-plus-fludrocortisone group reached a SOFA score below 6 faster than those in the placebo group,6\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4-turbo-preview", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}